Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
As at 2022-12-31 |
2021-01-01 to 2021-12-31 |
As at 2021-12-31 |
|---|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | ||||
| Name of reporting entity or other means of identification |
Medistim ASA
|
— | — | — |
| Domicile of entity |
Oslo
|
— | — | — |
| Legal form of entity |
|
— | — | — |
| Country of incorporation |
|
— | — | — |
| Address of entity's registered office |
|
— | — | — |
| Description of nature of entity's operations and principal activities |
|
— | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | ||||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | ||||
| Current inventories | — |
114 333
NOK
|
— |
97 413
NOK
|
| Current trade receivables | — |
101 657
NOK
|
— |
68 634
NOK
|
| Current trade payables | — |
24 470
NOK
|
— |
13 205
NOK
|
| Explanation of sources of estimation uncertainty with significant risk of causing material adjustment |
Use of estimates and judgement
|
— | — | — |
| Dividends recognised as distributions to owners per share |
3.75
|
— |
3.00
|
— |